Glenmede Trust’s ProAssurance PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-634
Closed -$9K 1979
2020
Q3
$9K Sell
634
-124
-16% -$1.84K ﹤0.01% 1922
2020
Q2
$10K Buy
758
+102
+16% +$1.75K ﹤0.01% 1874
2020
Q1
$23K Hold
656
﹤0.01% 2021
2019
Q4
$23K Buy
656
+226
+53% +$8.66K ﹤0.01% 2021
2019
Q3
$17 Buy
430
+90
+26% +$3.49K ﹤0.01% 2126
2019
Q2
$12 Buy
340
+158
+87% +$5.88K ﹤0.01% 2293
2019
Q1
$6 Hold
182
﹤0.01% 2561
2018
Q4
$7 Buy
+182
New +$7.81K ﹤0.01% 2436
2018
Q2
Sell
-497
Closed -$28K 2230
2018
Q1
$28K Hold
497
﹤0.01% 1835
2017
Q4
$28K Sell
497
-224
-31% -$13.1K ﹤0.01% 1835
2017
Q3
$39K Buy
+721
New +$40.8K ﹤0.01% 1731

Other funds holding PRA

Glenmede Trust's PRA Position: Q4 2020 in Review

Glenmede Trust sold out of ProAssurance (PRA) in Q4 2020, closing a stake of 634 shares — an estimated $9K sold.

Glenmede Trust first reported a position in PRA in Q3 2017 and held it in 11 quarters. The position peaked at $39K in Q3 2017. 169 funds tracked by Wall St. Rank hold PRA as of Q4 2020.

  • Glenmede Trust reported no remaining ProAssurance position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 634 ProAssurance shares in Q4 2020, an estimated $9K.
  • Glenmede Trust first reported a position in ProAssurance in Q3 2017 and held it in 11 quarters.
  • Glenmede Trust's ProAssurance position peaked at $39K in Q3 2017.
  • 169 funds tracked by Wall St. Rank held ProAssurance as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.